This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Polytherics Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovator Ian Glassford: Pioneering Cytotoxic Agents
Introduction: Ian Glassford is a prominent inventor based in King of Prussia, Pennsylvania, known for his contributions to the field of pharmacology. With a focus on cytotoxic agents, he has developed innovative solutions that hold promise in the realm of cancer therapy. His work reflects a strong commitment to enhancing therapeutic methods and improving patient outcomes.
Latest Patents: Ian Glassford has been awarded a patent for his invention titled "Cytotoxic Agents and Conjugates Thereof." This patent encompasses novel maytansinoid compounds, which are characterized by a general formula I. The invention details the creation of conjugates that link these compounds to binding proteins via a linker, alongside conjugating reagents that have the compounds attached to functional groups capable of interacting with binding proteins. Furthermore, the patent outlines pharmaceutical compositions comprising these compounds and conjugates, along with therapeutic methods and applications, particularly in cancer treatment and novel synthetic processes.
Career Highlights: Ian Glassford's career is marked by his role at Polytherics Limited, where he has made significant contributions to the field of drug development. His work has positioned him as an influential figure in the pharmaceutical industry, particularly in the development of targeted therapies.
Collaborations: Throughout his career, Ian has collaborated with notable professionals including Nareshkumar Jain and Sanjeevani Ghone. These partnerships have enriched the research process, fostering innovative ideas and expediting the development of vital therapeutic agents.
Conclusion: Ian Glassford's contributions to the field of cytotoxic agents and innovative therapies exemplify the spirit of invention and collaboration. His work not only advances scientific knowledge but also enhances the potential for developing effective cancer treatments, making him a valuable asset in the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile